Highlights

  1. Open Access • Continuous Publication

    AnKa Publisher stands as an independent, fully Open Access scholarly publisher profoundly dedicated to the global dissemination, meticulous preservation, and continuous advancement of academic, philosophical, and scientific knowledge.

    Articles are published online dynamically - Continuous Publication model -  as soon as they successfully navigate rigorous peer review, comprehensive editorial curation, and final technical production—freeing authors from waiting for scheduled issue completions.

    Read more

  2. Join Our Editorial Masthead!

    Feline Coronaviruses: Research, Pathogenesis and Therapeutics is building its Editorial Masthead and invites distinguished clinicians, virologists, immunologists, pharmacologists, and veterinary researchers from around the world to join our editorial team. We seek experts in feline coronavirus virology, FIP pathogenesis, molecular diagnostics, antiviral therapeutics (including GS-441524 and remdesivir), viral evolution and mutation, feline immunology, vaccinology, epidemiology, and translational veterinary medicine. As a member of our Editorial Masthead, you will play a pivotal role in shaping the scientific direction of the journal, guiding rigorous peer review, and advancing the global understanding of FCoV and FIP—ultimately contributing to improved diagnosis, treatment, and prevention strategies for feline patients worldwide. We invite you to visit our Editorial Masthead page to learn more about this opportunity and to join us in this vital mission.

    Read more

  3. Call for Submissions

    Feline Coronaviruses: Research, Pathogenesis and Therapeutics is now accepting submissions from veterinary clinicians, virologists, immunologists, pharmacologists, and researchers across all disciplines related to Feline Coronavirus (FCoV) and Feline Infectious Peritonitis (FIP). As a newly established, peer-reviewed, open-access journal dedicated exclusively to FCoV research, we are committed to publishing high-quality original research, comprehensive reviews, case reports, and methodological innovations that advance the understanding and clinical management of these devastating feline diseases. We operate on a continuous publication model, meaning accepted articles are published online without delay, ensuring rapid dissemination of your findings to the global scientific and veterinary community. We invite you to explore our Author Guidelines for detailed information on manuscript preparation, formatting, and submission policies. Submit your exceptional research today and contribute to advancing feline health at the intersection of virology, immunology, therapeutics, and clinical veterinary medicine.

    Read more

Feline Coronaviruses: Research, Pathogenesis and Therapeutics is a premier, peer-reviewed international journal dedicated to advancing the scientific understanding of feline coronaviruses (FCoV) and their associated clinical outcomes. The journal serves as a comprehensive platform for interdisciplinary research, bridging fundamental virology with translational clinical applications. Our mission is to catalyze progress in the prevention, diagnosis, and treatment of FCoV-related diseases through the dissemination of high-quality original research, critical reviews, and cutting-edge technological innovations.

Our scope rigorously covers, but is not limited to, the following core areas:

  • Molecular Virology & Viral Evolution: Genetic characterization, phylogenetic analysis, and the molecular mechanisms underlying the biotype switch from avirulent FCoV to virulent FIPV (Feline Infectious Peritonitis Virus).

  • Epidemiology & Host Dynamics: Transmission patterns, risk factors, and the prevalence of FCoV in diverse feline populations, including domestic cats, breeding catteries, and wild felids.

  • Host-Pathogen Interactions & Immunology: Innate and adaptive immune responses to FCoV infection, immune evasion strategies, cytokine storm syndromes, and the immunopathogenesis of FIP.

  • Advanced Diagnostics: Development and validation of sensitive and specific molecular assays (RT-qPCR, sequencing), serological biomarkers, and point-of-care testing for early and accurate FCoV detection.

  • Antiviral Therapeutics: Preclinical and clinical evaluations of novel antiviral agents, including nucleoside analogs (e.g., GS-441524, remdesivir, molnupiravir), immunomodulatory drugs, and combination therapy regimens.

  • Vaccine Research & Prophylaxis: Design and testing of next-generation vaccines, including mRNA, viral-vector, and subunit vaccine platforms aimed at preventing FCoV infection or FIP development.

  • Pathology & Clinical Management: Histopathological characterization of FCoV-associated lesions, clinical case management protocols, and long-term outcomes of treated patients.

  • Public Health & One Health Perspectives: Surveillance of FCoV as a model for coronavirus biology, comparative coronavirology, and the implications of antiviral resistance.

By fostering collaboration among virologists, immunologists, veterinarians, pharmacologists, and molecular biologists, Feline Coronaviruses: Research, Pathogenesis and Therapeutics aspires to be the definitive global reference for the scientific community, ultimately translating bench-side discoveries into tangible benefits for feline health and welfare.